SUPASIL

This brand name is authorized in Nigeria.

Active ingredients

The drug SUPASIL contains one active pharmaceutical ingredient (API):

1	Cefepime UNII I8X1O0607P - CEFEPIME HYDROCHLORIDE
	Cefepime is a broad-spectrum, bactericidal antibiotic, with activity against a wide range of Gram-positive and Gram-negative bacteria, including many strains resistant to aminoglycosides or third generation cephalosporins. It has a reduced affinity for beta-lactamases.
	Read more about Cefepime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100540	Injection	SUPASIL INJECTION INJ 1 g 10ML	23 NF-PP-339577 SUPASIL INJECTION 1G CEFEPIME FOR INJECTION USP 1G Cefepime hydrochloride USP Equivalent to Cefepime - 1g (Sterile mixture of Cefepime hydrochloride & L-Arginine) Sterile Water for Injection USP - 10ml Drugs Imported Products 11vial Prescription Only Medicine (POM) 7/18/2023 SUPERIOR PHARMACEUTICALS LIMITED, 9B, ROBINSON GBAGI STREET, AJAO ESTATE 8029403780 superiorpharmang@gmail.com ANTILA LIFESCIENCES PVT.LTD @ INJECT CARE PARENTERALS PVT.LTD, Plot No. 130 Silvassa Road GIDC Vapi - 396195, Gujarat India, India	28/09/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DE01	Cefepime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DE Fourth-generation cephalosporins
Discover more medicines within J01DE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100540